CIK: 1629383 - Address: C/O Avidity Biosciences, Inc., 10578 Science Center Drive, Suite 125, San Diego, CA 92121
36 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11221-2-2-3013-3
S%wins505010050100058

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/23/24 21:01
9/23/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS-1,44744.000-33-10297D
8/7/24 17:46
8/6/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d351.2402816205D
8/7/24 17:46
8/6/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-1,21443.350-28-12205D
7/11/24 16:07
7/9/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d351.2402816205D
7/11/24 16:07
7/9/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-1,11839.930-28-12205D
6/21/24 17:01
6/18/24
OABIOmniab, Inc.DEHealthBiolabCommercial Physical & BiologiBoyce SarahCADM.d00.000204168D
6/20/24 18:47
6/18/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS-1,25539.130-32-14205D
6/14/24 18:58
6/12/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.dm3721.240300112D
6/14/24 18:58
6/12/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-11,58838.630-300-73112D
6/5/24 17:46
6/4/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d351.2402833112D
6/5/24 17:46
6/4/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-76827.420-28-20112D
5/7/24 21:52
5/7/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d351.2402833112D
5/7/24 21:52
5/7/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-71525.540-28-20112D
4/3/24 18:16
4/2/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d351.2402833112D
4/3/24 18:16
4/2/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-73526.250-28-20112D
3/12/24 17:29
3/8/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.dm1391.240112999%112D
3/12/24 17:29
3/8/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-2,43021.700-112-50112D
3/5/24 16:53
3/1/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d1041.24084299112D
3/5/24 16:53
3/1/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-1,69120.130-84-43112D
1/23/24 15:13
1/22/24
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-5210.130-5-1044D
2/3/23 17:26
2/1/23
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.dm621.24050999%53D
2/3/23 17:26
2/1/23
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-1,21824.350-50-4853D
11/14/22 16:30
11/9/22
OABIOmniab, Inc.DEHealthBiolabCommercial Physical & BiologiBoyce SarahCADP.m1012.820366988I
8/26/22 19:29
8/24/22
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.dm621.240500D
8/26/22 19:29
8/24/22
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.dm-1,14222.880-50-1000D
8/17/22 21:40
8/15/22
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOM.d01.24000D
8/17/22 21:40
8/15/22
RNAAvidity Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahCADOP,CEOS.d-222.4700-1000D
3/3/21 21:22
3/1/21
BLIBerkeley Lights, Inc.DEElectrLabEqLaboratory Analytical InstrumBoyce SarahCADM.d898.900100D
3/3/21 21:22
3/1/21
BLIBerkeley Lights, Inc.DEElectrLabEqLaboratory Analytical InstrumBoyce SarahCADS.d-61161.130-10-1000D
7/17/19 16:52
7/15/19
AKCAAkcea Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBoyce SarahMADOPS-4323.520-2-820D
1/17/18 21:23
1/15/18
IONSIonis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsBoyce SarahCAOChief BuM.d00.00051519D
1/17/18 21:23
1/16/18
IONSIonis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsBoyce SarahCAOChief BuS.d-11451.760-2-209D
1/18/17 18:48
1/15/17
IONSIonis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsBoyce SarahCAOChief BuM.d00.003331975D-32668618-13-1-5-1-100-10
1/18/17 18:48
1/17/17
IONSIonis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsBoyce SarahCAOChief BuS.d-6346.2933-1-215D-32668618-13-1-5-1-100-10
1/19/16 20:08
1/15/16
IONSIonis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsBoyce SarahCAOChief BuM.d00.003322D-8-36-230-24-26-25-10512-46-3013
1/19/16 20:08
1/19/16
IONSIonis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsBoyce SarahCAOChief BuS.d-3641.4633-1-332D-8-36-230-24-26-25-10512-46-3013

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact